scispace - formally typeset
B

Benoît Marin

Researcher at French Institute of Health and Medical Research

Publications -  146
Citations -  6165

Benoît Marin is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Population & Amyotrophic lateral sclerosis. The author has an hindex of 31, co-authored 144 publications receiving 5062 citations. Previous affiliations of Benoît Marin include Centre national de la recherche scientifique & University of Limoges.

Papers
More filters
Journal ArticleDOI

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

TL;DR: The results of a French prospective phase II trial of an L-asparaginase-containing regimen in 19 patients with relapsed or refractory disease treated in 13 centers confirm the excellent activity of L-Asparaginases-containing regimens in extranodal NK/T-cell lymphoma.
Journal ArticleDOI

Focused training for goal-oriented hand-held echocardiography performed by noncardiologist residents in the intensive care unit

TL;DR: Limited training of noncardiologist ICU residents without previous knowledge in ultrasound appears feasible and efficient to address simple clinical questions using point-of-care echography.
Journal ArticleDOI

Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients

TL;DR: Nutritional parameters of ALS patients worsened during evolution of the disease, and worse nutritional status (at time of diagnosis or during the course) was associated with a higher mortality.
Journal ArticleDOI

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

TL;DR: In the cART era, the most frequent non-AIDS-defining causes of death are associated with immunodeficiency, only cardiovascular disease was associated with high viral replication and no relationship between risk of death from cardiovascular disease and CD4 cell count was found.